Biohaven signs on as official sponsor for Music City Grand Prix
Participating in this sponsorship deal:
About Sponsor:
Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, Alzheimer's disease, and spinocerebellar ataxia; and MPO inhibition for multiple system atrophy and amyotrophic lateral sclerosis.
About Property:
The Music City Grand Prix, known as the Big Machine Music City Grand Prix for sponsorship reasons, is an IndyCar Series race that will be held at the Nashville Street Circuit in Nashville, Tennessee. The inaugural running of the race is scheduled for August 8, 2021.